⌘K

Home/Filings/4/0001654954-25-007737

4//SEC Filing

Doogan Declan 4

Accession 0001654954-25-007737

CIK 0000034956other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 8:12 AM ET

Size

9.5 KB

Accession

0001654954-25-007737

Insider Transaction Report

Form 4

Period: 2025-07-01

TENAX THERAPEUTICS, INC.TENX

Director

Transactions

Award
Stock Option (right to buy)
2025-07-01+80,000→ 80,000 total
Exercise: $5.75From: 2025-07-01Exp: 2035-07-01→ Common Stock (80,000 underlying)

Holdings

Stock Option (right to buy)
Exercise: $992.00From: 2023-06-09Exp: 2032-06-09→ Common Stock (4 underlying)
4
Stock Option (right to buy)
Exercise: $5.94From: 2025-12-10Exp: 2034-12-10→ Common Stock (100,000 underlying)
100,000
Common Stock
2,274
Stock Option (right to buy)
Exercise: $3200.00From: 2022-06-10Exp: 2031-06-10→ Common Stock (4 underlying)
4

Documents

1 file

4
section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

TENAX THERAPEUTICS, INC.

CIK 0000034956

Entity typeother

Related Parties

1

filerCIK 0001704234

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 8:12 AM ET
Size: 9.5 KB

View on SEC.gov